IL275758B2 - Injectable compositions of triterpenoid antifungals encapsulated in liposomes - Google Patents

Injectable compositions of triterpenoid antifungals encapsulated in liposomes

Info

Publication number
IL275758B2
IL275758B2 IL275758A IL27575820A IL275758B2 IL 275758 B2 IL275758 B2 IL 275758B2 IL 275758 A IL275758 A IL 275758A IL 27575820 A IL27575820 A IL 27575820A IL 275758 B2 IL275758 B2 IL 275758B2
Authority
IL
Israel
Prior art keywords
injectable composition
formula
compound
unilamellar vesicles
iia
Prior art date
Application number
IL275758A
Other languages
English (en)
Hebrew (he)
Other versions
IL275758A (en
IL275758B1 (en
Inventor
Rajeshwar Motheram
Original Assignee
Scynexis Inc
Rajeshwar Motheram
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scynexis Inc, Rajeshwar Motheram filed Critical Scynexis Inc
Publication of IL275758A publication Critical patent/IL275758A/en
Publication of IL275758B1 publication Critical patent/IL275758B1/en
Publication of IL275758B2 publication Critical patent/IL275758B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
IL275758A 2018-01-02 2018-12-21 Injectable compositions of triterpenoid antifungals encapsulated in liposomes IL275758B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862612893P 2018-01-02 2018-01-02
PCT/US2018/067216 WO2019135954A1 (en) 2018-01-02 2018-12-21 Injectable compositions of triterpenoid antifungals encapsulated in liposomes

Publications (3)

Publication Number Publication Date
IL275758A IL275758A (en) 2020-08-31
IL275758B1 IL275758B1 (en) 2025-03-01
IL275758B2 true IL275758B2 (en) 2025-07-01

Family

ID=65024141

Family Applications (2)

Application Number Title Priority Date Filing Date
IL275758A IL275758B2 (en) 2018-01-02 2018-12-21 Injectable compositions of triterpenoid antifungals encapsulated in liposomes
IL318793A IL318793A (en) 2018-01-02 2018-12-21 Injectable compositions of antifungal triterpenoids encapsulated in liposomes

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL318793A IL318793A (en) 2018-01-02 2018-12-21 Injectable compositions of antifungal triterpenoids encapsulated in liposomes

Country Status (27)

Country Link
US (3) US20200338002A1 (https=)
EP (2) EP4137123A1 (https=)
JP (3) JP7378401B2 (https=)
KR (1) KR102694692B1 (https=)
CN (2) CN115998684A (https=)
AU (1) AU2018399599B2 (https=)
CA (1) CA3087176A1 (https=)
DK (1) DK3735226T3 (https=)
EA (1) EA202091626A1 (https=)
ES (1) ES2927051T3 (https=)
HR (1) HRP20221295T1 (https=)
HU (1) HUE060400T2 (https=)
IL (2) IL275758B2 (https=)
LT (1) LT3735226T (https=)
MA (1) MA51514A (https=)
MD (1) MD3735226T2 (https=)
MX (1) MX2020006992A (https=)
PL (1) PL3735226T3 (https=)
PT (1) PT3735226T (https=)
RS (1) RS63687B1 (https=)
SA (1) SA520412362B1 (https=)
SG (1) SG11202006313WA (https=)
SI (1) SI3735226T1 (https=)
SM (1) SMT202200427T1 (https=)
TW (2) TWI857944B (https=)
UA (1) UA126096C2 (https=)
WO (1) WO2019135954A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3087176A1 (en) * 2018-01-02 2019-07-11 Scynexis, Inc. Injectable compositions of triterpenoid antifungals encapsulated in liposomes

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120058178A1 (en) * 2009-03-30 2012-03-08 Eisai R&D Management Co., Ltd. Liposome Composition
US8188085B2 (en) * 2008-08-12 2012-05-29 Merck Sharp & Dohme Corp. Antifungal agents
US20160207956A1 (en) * 2015-01-19 2016-07-21 Scynexis, Inc. Novel salts and polymorphs of scy-078

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756472A (en) 1996-01-31 1998-05-26 Merck & Co., Inc. Antifungal agent obtained from hormonema
US7718189B2 (en) * 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
NZ548195A (en) * 2004-01-14 2011-01-28 Gilead Sciences Inc Lipid-based dispersions useful for drug delivery
JP5245057B2 (ja) 2006-04-03 2013-07-24 メルク・シャープ・アンド・ドーム・コーポレーション 抗真菌剤
CN101861150B (zh) * 2007-09-28 2014-07-16 默克夏普和道赫莫公司 抗真菌制剂
JP2011518844A (ja) * 2008-04-25 2011-06-30 ナノバイオ コーポレーション 真菌、酵母および糸状菌感染症を治療するためのナノエマルション
AU2009275230A1 (en) * 2008-07-23 2010-01-28 Targeted Delivery Technologies Limited Methods of administering topical antifungal formulations for the treatment of fungal infections
CA3087176A1 (en) * 2018-01-02 2019-07-11 Scynexis, Inc. Injectable compositions of triterpenoid antifungals encapsulated in liposomes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8188085B2 (en) * 2008-08-12 2012-05-29 Merck Sharp & Dohme Corp. Antifungal agents
US20120058178A1 (en) * 2009-03-30 2012-03-08 Eisai R&D Management Co., Ltd. Liposome Composition
US20160207956A1 (en) * 2015-01-19 2016-07-21 Scynexis, Inc. Novel salts and polymorphs of scy-078

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANITA MCCUTCHEON J, REES DOYLE G., CLINICAL PROCEDURES FOR SAFER PATIENT CARE, 23 November 2015 (2015-11-23) *
PEER D., ET AL., NANOCARRIERS AS AN EMERGING PLATFORM FOR CANCER THERAPY, 31 December 2007 (2007-12-31) *

Also Published As

Publication number Publication date
US20230277455A1 (en) 2023-09-07
LT3735226T (lt) 2022-11-10
EP3735226B1 (en) 2022-08-10
KR20200105875A (ko) 2020-09-09
JP7378401B2 (ja) 2023-11-13
SMT202200427T1 (it) 2022-11-18
JP2024012452A (ja) 2024-01-30
DK3735226T3 (da) 2022-10-24
JP2025106349A (ja) 2025-07-15
HUE060400T2 (hu) 2023-02-28
SA520412362B1 (ar) 2022-12-15
US20250082574A1 (en) 2025-03-13
CN115998684A (zh) 2023-04-25
HRP20221295T1 (hr) 2022-12-23
SI3735226T1 (sl) 2022-11-30
RS63687B1 (sr) 2022-11-30
BR112020013448A2 (pt) 2020-12-01
EA202091626A1 (ru) 2020-09-22
IL318793A (en) 2025-04-01
WO2019135954A1 (en) 2019-07-11
MD3735226T2 (ro) 2023-03-31
PT3735226T (pt) 2022-09-20
TW201929853A (zh) 2019-08-01
TW202434242A (zh) 2024-09-01
KR102694692B1 (ko) 2024-08-14
EP4137123A1 (en) 2023-02-22
MX2020006992A (es) 2020-09-09
UA126096C2 (uk) 2022-08-10
CA3087176A1 (en) 2019-07-11
NZ765771A (en) 2024-09-27
JP2021508728A (ja) 2021-03-11
MA51514A (fr) 2021-04-07
IL275758A (en) 2020-08-31
IL275758B1 (en) 2025-03-01
AU2018399599A1 (en) 2020-07-16
ES2927051T3 (es) 2022-11-02
TWI857944B (zh) 2024-10-11
SG11202006313WA (en) 2020-07-29
CN111655237B (zh) 2023-02-03
EP3735226A1 (en) 2020-11-11
PL3735226T3 (pl) 2022-12-19
CN111655237A (zh) 2020-09-11
TWI862280B (zh) 2024-11-11
US20200338002A1 (en) 2020-10-29
AU2018399599B2 (en) 2022-09-01

Similar Documents

Publication Publication Date Title
JP5645954B2 (ja) イリノテカン又はその塩酸塩のリポソーム及びその製造方法
US20050238706A1 (en) Pharmaceutically active lipid based formulation of SN-38
IL275758B2 (en) Injectable compositions of triterpenoid antifungals encapsulated in liposomes
JP2021508728A5 (https=)
CN104971062B (zh) 伊立替康类药物和氯喹类药物组合及其共载脂质体和制备
NZ765771B2 (en) Injectable compositions of triterpenoid antifungals encapsulated in liposomes
JPWO2019135954A5 (https=)
HK40090116A (en) Injectable compositions of triterpenoid antifungals encapsulated in liposomes
HK40036677A (en) Injectable compositions of triterpenoid antifungals encapsulated in liposomes
Brunet et al. Enhancement of amphotericin B activity against Cryptococcus neoformans using lipid nanoparticles
HK40036677B (en) Injectable compositions of triterpenoid antifungals encapsulated in liposomes
HK40040387B (en) Injectable compositions of triterpenoid antifungals encapsulated in liposomes
HK40040387A (en) Injectable compositions of triterpenoid antifungals encapsulated in liposomes
BR112020013448B1 (pt) Composição injetável, método para preparar uma composição injetável, e, uso da composição injetável
EA045936B1 (ru) Инъецируемые композиции, обладающие противогрибковой активностью, и способы их получения и применения